Advertisement
Advertisement
November 30, 2017
CryoLife Completes Acquisition of Jotec
December 1, 2017—CryoLife, Inc., a United States-based medical device and tissue processing company focused on cardiac and vascular surgery, announced that it has completed its previously announced acquisition of Jotec GmbH, a German-based, privately held developer of technologically differentiated endovascular stent grafts and cardiac and vascular surgical grafts, focused on aortic repair.
In October, the companies announced the agreement under which CryoLife would acquire Jotec for $225 million, consisting of 75% in cash and up to 25% in CryoLife common stock issued to Jotec’s shareholders. The acquisition creates an international company with more than 1,000 employees dedicated to the field of medical products for cardiovascular surgery.
Advertisement
Advertisement
